The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
name | description |
---|---|
PK_1cmt | One compartment PK model with linear clearance |
PK_1cmt_des | One compartment PK model with linear clearance using differential equations |
PK_2cmt | Two compartment PK model with linear clearance |
PK_2cmt_des | Two compartment PK model with linear clearance using differential equations |
PK_2cmt_no_depot | Two compartment PK model with linear clearance using differential equations |
PK_2cmt_tdcl_des | Two compartment PK model with time-dependent clearance using differential equations (structured like nivolumab PK model) |
PK_3cmt | Three compartment PK model with linear clearance |
PK_3cmt_des | Three compartment PK model with linear clearance using differential equations |
phenylalanine_charbonneau_2021 | Phenylalanine model for absorption and metabolism in healthy subjects and patients with PKU |
indirect_0cpt_transitEx | Two compartment PK model with Michealis-Menten clearance using differential equations |
indirect_1cpt_inhi_kin | One compartment indirect response model with inhibition of kin. |
indirect_1cpt_inhi_kin_CLV | One compartment indirect response model with inhibition of kin. |
indirect_1cpt_inhi_kin_r0rmaxcrmax | One compartment indirect response model with inhibition of kin. |
indirect_1cpt_inhi_kout | One compartment indirect response model with inhibition of kout. |
indirect_1cpt_inhi_kout_CLV | One compartment indirect response model with inhibition of kout. |
indirect_1cpt_inhi_kout_r0rmaxcrmax | One compartment indirect response model with inhibition of kout. |
indirect_1cpt_stim_kin | One compartment indirect response model with stimulation of kin.Parameterized using rate cosntants |
indirect_1cpt_stim_kin_CLV | One compartment indirect response model with stimulation of kin. |
indirect_1cpt_stim_kin_r0rmaxcrmax | One compartment indirect response model with stimulation of kin. |
indirect_1cpt_stim_kout | One compartment indirect response model with stimulation of kout.Parameterized using rate cosntants |
indirect_1cpt_stim_kout_CLV | One compartment indirect response model with stimulation of kout. |
indirect_1cpt_stim_kout_r0rmaxcrmax | One compartment indirect response model with stimulation of kout. |
indirect_circ_1cpt_inhi_kin_kin_t | One compartment indirect response model with inhibition of kin and circadian kin_t. |
indirect_circ_1cpt_inhi_kin_kout_t | One compartment indirect response model with inhibition of kin and circadian kin_t. |
indirect_circ_1cpt_inhi_kout_kin_t | One compartment indirect response model with inhibition of kout and circadian kin_t. |
indirect_circ_1cpt_inhi_kout_kout_t | One compartment indirect response model with inhibition of kout and circadian kin_t. |
indirect_circ_1cpt_stim_kin_kin_t | One compartment indirect response model with stimulation of kin and circadian kin_t.Parameterized using rate cosntants |
indirect_circ_1cpt_stim_kin_kout_t | One compartment indirect response model with stimulation of kin and circadian kout_t.Parameterized using rate constants |
indirect_circ_1cpt_stim_kout_kin_t | One compartment indirect response model with stimulation of kout and circadian kin_t.Parameterized using rate cosntants |
indirect_circ_1cpt_stim_kout_kout_t | One compartment indirect response model with stimulation of kout and circadian kout_t.Parameterized using rate cosntants |
indirect_prec_1cpt_inhi_CLV | One compartment precursor-dependent indirect response model with inhibition of drug response. Parameterized with clearance and volume. (effect). |
indirect_prec_1cpt_inhi_r0rmaxcrmax | One compartment precursor-dependent indirect response model with inhibition of drug response (effect). |
indirect_prec_1cpt_stim_CLV | One compartment precursor-dependent indirect response model with inhibition of drug response (effect). Parameterized with clearance and volume |
indirect_prec_1cpt_stim_r0rmaxcrmax | One compartment precursor-dependent indirect response model with inhibition of drug response (effect). Parameterized with clearance and volume |
PK_2cmt_mAb_Davda_2014 | Two compartment PK model with linear clearance for average monoclonal antibodies (Davda 2014) |
PK_double_sim_01 | PK double absorption model with simultaneous zero order and first order absorptions |
PK_double_sim_10 | PK double absorption model with simultaneous first order and zero order absorptions |
PK_double_sim_11 | PK double absorption model with simultaneous first order absorptions |
CarlssonPetri_2021_liraglutide | Liraglutide PK model in adolescents (Carlsson Petri 2021) |
Cirincione_2017_exenatide | Exenatide immediate-release PK model (Cirincione 2017) |
Kovalenko_2020_dupilumab | Dupilumab PK model (Kovalenko 2020) |
Soehoel_2022_tralokinumab | Tralokinumab PK model (Soehoel 2022) |
Zhu_2017_lebrikizumab | Lebrikizumab PK model (Zhu 2017) |
oncology_sdm_lobo_2002 | Signal transduction model for delayed concentration effects on cancer cell growth |
oncology_xenograft_simeoni_2004 | Oncology tumor growth model in xenograft models |
tgi_no_sat_Koch | One compartment TGI model with with exponential tumor growth, without saturation. |
tgi_no_sat_expo | One compartment TGI model with with exponential tumor growth, without saturation. |
tgi_no_sat_linear | One compartment TGI model with with linear tumor growth, without saturation. |
tgi_no_sat_powerLaw | One compartment TGI model with with exponential tumor growth, without saturation. |
tgi_sat_VonBertalanffy | One compartment TGI model where tumor growth is limited by a loss term, with saturation. |
tgi_sat_genVonBertalanffy | One compartment TGI model where tumor growth is limited by a loss term, with saturation. |
tgi_sat_logistic | One compartment TGI model with with exponential tumor growth that decelerates linearly, with saturation. |
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.